| LDR | 01058nam a22002651i 4500 | ||
| 001 | 000090910 | ||
| 003 | MiAaHDL | ||
| 005 | 20210817000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 880715s1977 mdu b f00010 eng d | ||
| 035 | ⊔ | ⊔ | ‡a(MiU)990000909100106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990000909100106381 |
| 035 | ⊔ | ⊔ | ‡asdr-umn002311697 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)3598455 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)160064213 |
| 035 | ⊔ | ⊔ | ‡a(RLIN)MIUG3598455-B |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph000090910 |
| 040 | ⊔ | ⊔ | ‡aDHEW ‡cDHEW ‡dCLU ‡dTxHMC ‡dMiU ‡dCStRLIN |
| 060 | ⊔ | ⊔ | ‡aQV 771 U57g 1977 |
| 086 | ⊔ | ⊔ | ‡aII0 aHE 20.4208/2:C 61 |
| 110 | 1 | ⊔ | ‡aUnited States. ‡bFood and Drug Administration. ‡bBureau of Drugs. |
| 245 | 1 | 0 | ‡aGeneral considerations for the clinical evaluation of drugs. |
| 260 | ⊔ | ⊔ | ‡aRockville, Md. : ‡bU.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ; ‡aWashington : ‡bfor sale by the Supt. of Docs., U.S. Govt. Print. Off., ‡c1977. |
| 300 | ⊔ | ⊔ | ‡aiii, 11 p. ; ‡c27 cm. |
| 490 | 0 | ⊔ | ‡aDHEW publication ; no. (FDA) 77-3040 |
| 490 | 0 | ⊔ | ‡aFDA Bureau of Drugs clinical guidelines |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 2 | ‡aDrug Evaluation |
| 650 | ⊔ | 0 | ‡aPharmacology |
| 650 | ⊔ | 0 | ‡aDrugs ‡xTesting |
| CID | ⊔ | ⊔ | ‡a000090910 |
| DAT | 0 | ⊔ | ‡a19880715000000.0 ‡b20210817000000.0 |
| DAT | 1 | ⊔ | ‡a20210923060709.0 ‡b2023-08-07T17:33:59Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990000909100106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015003205054 ‡sMIU ‡1990000909100106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230807 ‡sgoogle ‡umdp.39015003205054 ‡y1977 ‡rpd ‡qbib ‡tUS fed doc |
| 974 | ⊔ | ⊔ | ‡bUMN ‡cUMN ‡d20230316 ‡sgoogle ‡uumn.31951003051226s ‡y1977 ‡rpd ‡qbib ‡tUS fed doc |